{"id":"W2097168611","doi":"10.1111/dme.12624","title":"Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double‐blind placebo‐controlled 102‐week trial","year":2014,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"AstraZeneca","keywords":"Dapagliflozin; Medicine; Metformin; Placebo; Type 2 diabetes; Internal medicine; Regimen; Diabetes mellitus; Adverse effect; Gastroenterology; Urinary system; Urology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002265267,0.0003865448,0.00291854,0.0004489454,0.0000424655,0.00001278762,0.0001190802,0.0001120572,0.0003014725],"category_scores_gemma":[0.0007206557,0.0002292123,0.0001169915,0.0005050031,0.0003850928,0.00005945352,0.00003741681,0.0001820527,0.0000106373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005212449,"about_ca_system_score_gemma":0.00007070079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005994066,"about_ca_topic_score_gemma":0.00003773834,"domain_scores_codex":[0.9973451,0.0002992499,0.0009386566,0.0004594125,0.0004982186,0.0004593414],"domain_scores_gemma":[0.997091,0.001744242,0.0003234821,0.0004917588,0.0001139764,0.0002355681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9860206,0.0008094407,0.003293685,0.0002173107,0.001150366,0.000005755382,0.001044953,0.00001819779,0.000327284,0.000533664,0.0002718002,0.006306901],"study_design_scores_gemma":[0.9850362,0.00668708,0.002441687,0.0008298219,0.001740447,7.247754e-7,0.0001119452,0.001606038,0.0002339841,0.0001190675,0.0009855081,0.0002075177],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799251,0.001635744,0.0001299632,0.002129007,0.0002679376,0.008212939,0.000001276056,0.00005267793,0.00764536],"genre_scores_gemma":[0.9962467,0.0006429279,0.0003435099,0.0006255883,0.0002773235,0.0005534493,0.00007390066,0.00004957843,0.00118703],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0163216,"threshold_uncertainty_score":0.9347007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01651143501060446,"score_gpt":0.2660443147436545,"score_spread":0.2495328797330501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}